Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	New Amedeo service: Amedeo COVID-19 (formerly 2019-nCoV) Weekly publication summary

Breast Cancer

Free Subscription 13.01.2020 1 Ann Oncol 7 Ann Surg Oncol 6 Anticancer Res 7 BMC Cancer 1 BMJ 1 Br J Cancer 8 Breast Cancer 1 Breast Cancer (Dove Med Press) 5 Breast Cancer Res 9 Breast Cancer Res Treat 3 Breast J 2 Cancer 1 Cancer Chemother Pharmacol 1 Cancer Epidemiol Biomarkers Prev 2 Cancer Lett 4 Cancer Res 2 Clin Breast Cancer 2 Clin Cancer Res 2 Eur J Cancer 2 Eur J Surg Oncol 2 Eur Radiol 1 Gene 4 Int J Cancer 2 Int J Oncol 2 Int J Radiat Oncol Biol Phys 1 J Biol Chem 1 J Natl Cancer Inst 1 J Surg Oncol 1 Lancet 1 Lancet Oncol 2 N Engl J Med 2 Nature 3 Oncol Rep 1 Oncology 1 PLoS Genet 1 PLoS Med 4 PLoS One 1 Radiology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Oncol

1. HEIL J, Kuerer HM, Pfob A, Rauch G, et al
   Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges.
   Ann Oncol. 2020;31:61-71.
   PubMed     Text format     Abstract available
   
   

   
   Ann Surg Oncol

2. SMITH BL, Lanahan CR, Specht MC, Kelly BN, et al
   Feasibility Study of a Novel Protease-Activated Fluorescent Imaging System for Real-Time, Intraoperative Detection of Residual Breast Cancer in Breast Conserving Surgery.
   Ann Surg Oncol. 2020 Jan 2. pii: 10.1245/s10434-019-08158.
   PubMed     Text format     Abstract available
   
   
3. STANKOWSKI-DRENGLER TJ, Schumacher JR, Hanlon B, Livingston-Rosanoff D, et al
   Outcomes for Patients with Residual Stage II/III Breast Cancer Following Neoadjuvant Chemotherapy (AFT-01).
   Ann Surg Oncol. 2020 Jan 3. pii: 10.1245/s10434-019-07846.
   PubMed     Text format     Abstract available
   
   
4. SOLIMAN H, Wagner S, Flake DD 2nd, Robson M, et al
   Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
   Ann Surg Oncol. 2020 Jan 6. pii: 10.1245/s10434-019-08039.
   PubMed     Text format     Abstract available
   
   
5. SROUR MK, Amersi F
   Response to Letter to the Editor: "18FDG-PET/CT Imaging in Breast Cancer Patients with Clinical Stage IIB or Higher".
   Ann Surg Oncol. 2020 Jan 6. pii: 10.1245/s10434-019-08194.
   PubMed     Text format    
   
   
6. KANTOR O, Niu J, Zhao H, Giordano SH, et al
   Comparative Analysis of Proposed Strategies for Incorporating Biologic Factors into Breast Cancer Staging.
   Ann Surg Oncol. 2020 Jan 8. pii: 10.1245/s10434-019-08169.
   PubMed     Text format     Abstract available
   
   
7. SMITH BD, Lei X, Diao K, Xu Y, et al
   Effect of Surgeon Factors on Long-Term Patient-Reported Outcomes After Breast-Conserving Therapy in Older Breast Cancer Survivors.
   Ann Surg Oncol. 2020 Jan 8. pii: 10.1245/s10434-019-08165.
   PubMed     Text format     Abstract available
   
   
8. QIU PF, Zhao RR, Wang W, Sun X, et al
   Correction to: Internal Mammary Sentinel Lymph Node Biopsy in Clinically Axillary Lymph Node-Positive Breast Cancer: Diagnosis and Implications for Patient Management.
   Ann Surg Oncol. 2020 Jan 9. pii: 10.1245/s10434-020-08196.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

9. STEED KL, Jordan HR, Tollefsbol TO
   SAHA and EGCG Promote Apoptosis in Triple-negative Breast Cancer Cells, Possibly Through the Modulation of cIAP2.
   Anticancer Res. 2020;40:9-26.
   PubMed     Text format     Abstract available
   
   
10. PEREIRA MC, Mohammed R, VAN Otterlo WAL, DE Koning CB, et al
    In Vitro Analysis of the Combinatory Effects of Novel Aminonaphthoquinone Derivatives and Curcumin on Breast Cancer Progression.
    Anticancer Res. 2020;40:229-238.
    PubMed     Text format     Abstract available
    
    
11. BUONOMO OC, Grasso A, Pistolese CA, Anemona L, et al
    Evaluation of Concordance Between Histopathological, Radiological and Biomolecular Variables in Breast Cancer Neoadjuvant Treatment.
    Anticancer Res. 2020;40:281-286.
    PubMed     Text format     Abstract available
    
    
12. TAYEH S, Gera R, Perry N, Michell M, et al
    The Use of Magnetic Seeds and Radiofrequency Identifier Tags in Breast Surgery for Non-palpable Lesions.
    Anticancer Res. 2020;40:315-321.
    PubMed     Text format     Abstract available
    
    
13. MOTOMURA H, Nozaki Y, Onaga C, Ozaki A, et al
    High Expression of c-Met, PKClambda and ALDH1A3 Predicts a Poor Prognosis in Late-stage Breast Cancer.
    Anticancer Res. 2020;40:35-52.
    PubMed     Text format     Abstract available
    
    
14. JANSSEN S, Haus R, Schild SE, Rades D, et al
    A Simple Clinical Instrument to Predict the Survival Probability of Breast Cancer Patients Receiving Radiotherapy for Bone Metastases.
    Anticancer Res. 2020;40:367-371.
    PubMed     Text format     Abstract available
    
    

    
    BMC Cancer

15. AL-EITAN LN, Rababa'h DM, Alghamdi MA, Khasawneh RH, et al
    Association between ESR1, ESR2, HER2, UGT1A4, and UGT2B7 polymorphisms and breast Cancer in Jordan: a case-control study.
    BMC Cancer. 2019;19:1257.
    PubMed     Text format     Abstract available
    
    
16. HE J, Tsang JY, Xu X, Li J, et al
    AJCC 8th edition prognostic staging provides no better discriminatory ability in prognosis than anatomical staging in triple negative breast cancer.
    BMC Cancer. 2020;20:18.
    PubMed     Text format     Abstract available
    
    
17. DAGHER E, Royer V, Buchet P, Abadie J, et al
    Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.
    BMC Cancer. 2019;19:1267.
    PubMed     Text format     Abstract available
    
    
18. SKARPING I, Fornvik D, Sartor H, Heide-Jorgensen U, et al
    Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer.
    BMC Cancer. 2019;19:1272.
    PubMed     Text format     Abstract available
    
    
19. GLASER RL, York AE, Dimitrakakis C
    Incidence of invasive breast cancer in women treated with testosterone implants: a prospective 10-year cohort study.
    BMC Cancer. 2019;19:1271.
    PubMed     Text format     Abstract available
    
    
20. KIM CY, Kim N, Choung HK, In Khwarg S, et al
    Lacrimal drainage system stenosis associated with Trastuzumab emtansine (Kadcyla(R), T-DM1) administration: a case report.
    BMC Cancer. 2019;19:774.
    PubMed     Text format     Abstract available
    
    
21. SHAHI THAKURI P, Gupta M, Singh S, Joshi R, et al
    Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling.
    BMC Cancer. 2020;20:4.
    PubMed     Text format     Abstract available
    
    

    
    BMJ

22. MAHASE E
    AI system outperforms radiologists in first reading of breast cancer screening, study claims.
    BMJ. 2020;368:m16.
    PubMed     Text format    
    
    

    
    Br J Cancer

23. GUO W, Fensom GK, Reeves GK, Key TJ, et al
    Physical activity and breast cancer risk: results from the UK Biobank prospective cohort.
    Br J Cancer. 2020 Jan 10. pii: 10.1038/s41416-019-0700.
    PubMed     Text format     Abstract available
    
    

    
    Breast Cancer

24. ZHANG L, Zhang X, Zhang H, Liu F, et al
    Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing.
    Breast Cancer. 2020 Jan 9. pii: 10.1007/s12282-020-01045.
    PubMed     Text format     Abstract available
    
    
25. CHANG YK, Co M, Kwong A
    Conversion rate from mastectomy to breast conservation after neoadjuvant dual target therapy for HER2-positive breast cancer in the Asian population.
    Breast Cancer. 2020 Jan 8. pii: 10.1007/s12282-019-01037.
    PubMed     Text format     Abstract available
    
    
26. YOSHINAMI T, Koizumi K, Nagai SE, Toyama T, et al
    Dose-dense adjuvant chemotherapy: a systematic review and meta-analysis of the Japanese Breast Cancer Society Clinical Practice Guideline, 2018 edition.
    Breast Cancer. 2020 Jan 8. pii: 10.1007/s12282-019-01039.
    PubMed     Text format     Abstract available
    
    
27. ACUN T, Senses KM
    Downregulation of DNAJC10 (ERDJ5) is associated with poor survival in breast cancer.
    Breast Cancer. 2020 Jan 4. pii: 10.1007/s12282-019-01042.
    PubMed     Text format     Abstract available
    
    
28. BLOCKHUYS S, Brady DC, Wittung-Stafshede P
    Evaluation of copper chaperone ATOX1 as prognostic biomarker in breast cancer.
    Breast Cancer. 2020 Jan 2. pii: 10.1007/s12282-019-01044.
    PubMed     Text format     Abstract available
    
    
29. HE C, Kawaguchi K, Toi M
    DNA damage repair functions and targeted treatment in breast cancer.
    Breast Cancer. 2020 Jan 2. pii: 10.1007/s12282-019-01038.
    PubMed     Text format     Abstract available
    
    
30. TOPALOGLU US, Ozaslan E
    Comorbidity and polypharmacy in patients with breast cancer.
    Breast Cancer. 2020 Jan 2. pii: 10.1007/s12282-019-01040.
    PubMed     Text format     Abstract available
    
    
31. KURATA K, Kubo M, Kai M, Mori H, et al
    Microsatellite instability in Japanese female patients with triple-negative breast cancer.
    Breast Cancer. 2020 Jan 6. pii: 10.1007/s12282-019-01043.
    PubMed     Text format     Abstract available
    
    

    
    Breast Cancer (Dove Med Press)

32. MORADINAZAR M, Marzbani B, Shahebrahimi K, Shahabadi S, et al
    Hormone Therapy and Factors Affecting Fertility of Women Under 50-Year-Old with Breast Cancer.
    Breast Cancer (Dove Med Press). 2019;11:309-319.
    PubMed     Text format     Abstract available
    
    

    
    Breast Cancer Res

33. HADA M, Oh H, Pfeiffer RM, Falk RT, et al
    Relationship of circulating insulin-like growth factor-I and binding proteins 1-7 with mammographic density among women undergoing image-guided diagnostic breast biopsy.
    Breast Cancer Res. 2019;21:81.
    PubMed     Text format     Abstract available
    
    
34. MACPHERSON IR, Spiliopoulou P, Rafii S, Saggese M, et al
    A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer.
    Breast Cancer Res. 2019;22:1.
    PubMed     Text format     Abstract available
    
    
35. GAO Q, Lopez-Knowles E, Cheang MCU, Morden J, et al
    Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients.
    Breast Cancer Res. 2019;22:2.
    PubMed     Text format     Abstract available
    
    
36. GREGORY KJ, Roberts AL, Conlon EM, Mayfield JA, et al
    Gene expression signature of atypical breast hyperplasia and regulation by SFRP1.
    Breast Cancer Res. 2019;21:76.
    PubMed     Text format     Abstract available
    
    
37. WANG D, Naydenov NG, Dozmorov MG, Koblinski JE, et al
    Anillin regulates breast cancer cell migration, growth, and metastasis by non-canonical mechanisms involving control of cell stemness and differentiation.
    Breast Cancer Res. 2020;22:3.
    PubMed     Text format     Abstract available
    
    

    
    Breast Cancer Res Treat

38. NIRAVATH P, Hilsenbeck SG, Wang T, Jiralerspong S, et al
    Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia.
    Breast Cancer Res Treat. 2019;177:427-435.
    PubMed     Text format     Abstract available
    
    
39. BLACKWOOD J, Wright FC, Hong NJL, Gagliardi AR, et al
    Quality of DCIS information on the internet: a content analysis.
    Breast Cancer Res Treat. 2019;177:295-305.
    PubMed     Text format     Abstract available
    
    
40. YU Q, Huang K, Zhu Y, Chen X, et al
    Preliminary results of computer-aided diagnosis for magnetic resonance imaging of solid breast lesions.
    Breast Cancer Res Treat. 2019;177:419-426.
    PubMed     Text format     Abstract available
    
    
41. RIEDEL F, Heil J, Feisst M, Rezai M, et al
    Non-sentinel axillary tumor burden applying the ACOSOG Z0011 eligibility criteria to a large routine cohort.
    Breast Cancer Res Treat. 2019;177:457-467.
    PubMed     Text format     Abstract available
    
    
42. TYNAN M, Peshkin BN, Isaacs C, Willey S, et al
    Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients.
    Breast Cancer Res Treat. 2020 Jan 1. pii: 10.1007/s10549-019-05515.
    PubMed     Text format     Abstract available
    
    
43. KIM SS, Lee MH, Lee MO
    Histone methyltransferases regulate the transcriptional expression of ERalpha and the proliferation of tamoxifen-resistant breast cancer cells.
    Breast Cancer Res Treat. 2020 Jan 2. pii: 10.1007/s10549-019-05517.
    PubMed     Text format     Abstract available
    
    
44. WIJAYABAHU AT, Egan KM, Yaghjyan L
    Uterine cancer in breast cancer survivors: a systematic review.
    Breast Cancer Res Treat. 2020 Jan 2. pii: 10.1007/s10549-019-05516.
    PubMed     Text format     Abstract available
    
    
45. YAO S, Laurent CA, Roh JM, Lo J, et al
    Serum bone markers and risk of osteoporosis and fragility fractures in women who received endocrine therapy for breast cancer: a prospective study.
    Breast Cancer Res Treat. 2020 Jan 7. pii: 10.1007/s10549-019-05518.
    PubMed     Text format     Abstract available
    
    
46. YANG Y, Li S, Liu G, Shao Z, et al
    Is core needle biopsy effective at diagnosing male breast lesions?
    Breast Cancer Res Treat. 2019;177:507-511.
    PubMed     Text format     Abstract available
    
    

    
    Breast J

47. KUMAR M, Sebai ME, Appleford C, Dekhne N, et al
    Myxoma in the axilla of a patient with a history of inflammatory breast cancer.
    Breast J. 2020 Jan 2. doi: 10.1111/tbj.13741.
    PubMed     Text format    
    
    
48. DOE S, Petersen S, Swain M
    Utilization of genetic testing in breast cancer treatment after implementation of comprehensive multi-disciplinary care.
    Breast J. 2020 Jan 9. doi: 10.1111/tbj.13747.
    PubMed     Text format     Abstract available
    
    
49. ORLANDI A, Aroldi F, Garutti M, Di Dio C, et al
    Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more?
    Breast J. 2019 Dec 31. doi: 10.1111/tbj.13740.
    PubMed     Text format    
    
    

    
    Cancer

50. HERSHMAN DL, Accordino MK, Shen S, Buono D, et al
    Association between nonadherence to cardiovascular risk factor medications after breast cancer diagnosis and incidence of cardiac events.
    Cancer. 2020 Jan 8. doi: 10.1002/cncr.32690.
    PubMed     Text format     Abstract available
    
    
51. SHIN DW, Yu J, Cho J, Lee SK, et al
    Breast cancer screening disparities between women with and without disabilities: A national database study in South Korea.
    Cancer. 2020 Jan 6. doi: 10.1002/cncr.32693.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Chemother Pharmacol

52. LIANG Z, Feng A, Shim H
    MicroRNA-30c-regulated HDAC9 mediates chemoresistance of breast cancer.
    Cancer Chemother Pharmacol. 2020 Jan 6. pii: 10.1007/s00280-019-04024.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

53. SWEENEY MR, Sandler DP, Niehoff NM, White AJ, et al
    Shift work and working at night in relation to breast cancer incidence.
    Cancer Epidemiol Biomarkers Prev. 2020 Jan 8. pii: 1055-9965.EPI-19-1314.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Lett

54. GOH CY, Wyse C, Ho M, O'Beirne E, et al
    Exosomes in Triple Negative Breast Cancer: Garbage Disposals or Trojan Horses?
    Cancer Lett. 2020 Jan 2. pii: S0304-3835(19)30668.
    PubMed     Text format     Abstract available
    
    
55. BAROK M, Le Joncour V, Martins A, Isola J, et al
    ARX788, a novel anti-HER2 antibody-drug conjugate, shows anti-tumor effects in preclinical models of trastuzumab emtansine-resistant HER2-positive breast cancer and gastric cancer.
    Cancer Lett. 2020 Jan 2. pii: S0304-3835(19)30659.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

56. NIEHOFF NM, White AJ, Sandler DP
    Physical Activity and Breast Cancer: Focusing on High-Risk Subgroups and Putting Recommendations in Context.
    Cancer Res. 2020;80:23-24.
    PubMed     Text format     Abstract available
    
    
57. NIU Y, Bao L, Chen Y, Wang C, et al
    HIF-2-induced long non-coding RNA RAB11B-AS1 promotes hypoxia-mediated angiogenesis and breast cancer metastasis.
    Cancer Res. 2020 Jan 3. pii: 0008-5472.CAN-19-1532.
    PubMed     Text format     Abstract available
    
    
58. SANTORO AL, Drummond RD, da Silva IT, Ferreira SS, et al
    In situ DESI - MSI lipidomic profiles of breast cancer molecular subtypes and precursor lesions.
    Cancer Res. 2020 Jan 7. pii: 0008-5472.CAN-18-3574.
    PubMed     Text format     Abstract available
    
    
59. SANCHEZ-GONZALEZ I, Bobien A, Molnar C, Schmid S, et al
    miR-149 suppresses breast cancer metastasis by blocking paracrine interactions with macrophages.
    Cancer Res. 2020 Jan 7. pii: 0008-5472.CAN-19-1934.
    PubMed     Text format     Abstract available
    
    

    
    Clin Breast Cancer

60. MODI ND, Sorich MJ, Rowland A, McKinnon RA, et al
    Predicting Thrombocytopenia in Patients With Breast Cancer Treated With Ado-trastuzumab Emtansine.
    Clin Breast Cancer. 2019 Dec 7. pii: S1526-8209(19)30715.
    PubMed     Text format     Abstract available
    
    
61. LI Y, Wang YW, Chen X, Ma RR, et al
    MicroRNA-4472 Promotes Tumor Proliferation and Aggressiveness in Breast Cancer by Targeting RGMA and Inducing EMT.
    Clin Breast Cancer. 2019 Sep 11. pii: S1526-8209(19)30669.
    PubMed     Text format     Abstract available
    
    

    
    Clin Cancer Res

62. BYUN JS, Singhal S, Park S, Yi DI, et al
    Racial Differences in the Association between Luminal Master Regulator Gene Expression Levels and Breast Cancer Survival.
    Clin Cancer Res. 2020 Jan 7. pii: 1078-0432.CCR-19-0875.
    PubMed     Text format     Abstract available
    
    
63. POWLES RL, Wali VB, Li X, Barlow WE, et al
    Analysis of pre- and post-treatment tissues from the SWOG S0800 trial reveals an effect of neoadjuvant chemotherapy on the breast cancer genome.
    Clin Cancer Res. 2020 Jan 9. pii: 1078-0432.CCR-19-2405.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Cancer

64. BOERS J, Venema CM, de Vries EFJ, Glaudemans AWJM, et al
    Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibition.
    Eur J Cancer. 2019;126:11-20.
    PubMed     Text format     Abstract available
    
    
65. PONDE N, Amaye L, Lambertini M, Paesmans M, et al
    Trastuzumab emtansine (T-DM1)-associated cardiotoxicity: Pooled analysis in advanced HER2-positive breast cancer.
    Eur J Cancer. 2020;126:65-73.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Surg Oncol

66. FANCELLU A, Sanna V
    High mastectomy rates in young and very young patients with breast cancer. Are they justified?
    Eur J Surg Oncol. 2020 Jan 1. pii: S0748-7983(19)31520.
    PubMed     Text format    
    
    
67. AMELOT A, Terrier LM, Cristini J, Buffenoir K, et al
    Survival in breast cancer patients with spine metastases: Prognostic assessment involving molecular markers.
    Eur J Surg Oncol. 2019 Dec 25. pii: S0748-7983(19)31522.
    PubMed     Text format     Abstract available
    
    

    
    Eur Radiol

68. ZHU Y, Zhang Y, Ma Y, Li H, et al
    Cone-beam breast CT features associated with HER2/neu overexpression in patients with primary breast cancer.
    Eur Radiol. 2020 Jan 3. pii: 10.1007/s00330-019-06587.
    PubMed     Text format     Abstract available
    
    
69. ALABOUSI M, Zha N, Salameh JP, Samoilov L, et al
    Digital breast tomosynthesis for breast cancer detection: a diagnostic test accuracy systematic review and meta-analysis.
    Eur Radiol. 2020 Jan 3. pii: 10.1007/s00330-019-06549.
    PubMed     Text format     Abstract available
    
    

    
    Gene

70. DAI J, Chen Y, Gong Y, Gu D, et al
    Association of microRNA-27a rs895819 polymorphism with the risk of cancer: An updated meta-analysis.
    Gene. 2020;728:144185.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

71. ALIPOUR S
    Comments on: Hair dye and chemical straightener use and breast cancer risk in a large US population of black and white women.
    Int J Cancer. 2020 Jan 6. doi: 10.1002/ijc.32852.
    PubMed     Text format    
    
    
72. SONNENBLICK A, Salmon-Divon M, Salgado R, Dvash E, et al
    Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer.
    Int J Cancer. 2020 Jan 6. doi: 10.1002/ijc.32859.
    PubMed     Text format     Abstract available
    
    
73. CHOU WC, Hsiung CN, Chen WT, Tseng LM, et al
    A Functional Variant Near XCL1 Gene Improves Breast Cancer Survival via Promoting Cancer Immunity.
    Int J Cancer. 2020 Jan 6. doi: 10.1002/ijc.32855.
    PubMed     Text format     Abstract available
    
    
74. VANGANGELT KMH, Green AR, Heemskerk IMF, Cohen D, et al
    The prognostic value of the tumor-stroma ratio is most discriminative in patients with grade III or triple negative breast cancer.
    Int J Cancer. 2020 Jan 4. doi: 10.1002/ijc.32857.
    PubMed     Text format    
    
    

    
    Int J Oncol

75. LI Z, Zhang X, Hou C, Zhou Y, et al
    Comprehensive identification and characterization of somatic copy number alterations in triplenegative breast cancer.
    Int J Oncol. 2019 Dec 23. doi: 10.3892/ijo.2019.4950.
    PubMed     Text format     Abstract available
    
    
76. KIMURA R, Yoshimaru T, Matsushita Y, Matsuo T, et al
    The GALNT6LGALS3BP axis promotes breast cancer cell growth.
    Int J Oncol. 2019 Dec 13. doi: 10.3892/ijo.2019.4941.
    PubMed     Text format     Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

77. FANG LC
    Lead with Mastectomy.
    Int J Radiat Oncol Biol Phys. 2019;105:20-21.
    PubMed     Text format    
    
    
78. OHRI N, Haffty BG
    Mastectomy First, Keeping Chemotherapy and Radiation in Reserve.
    Int J Radiat Oncol Biol Phys. 2019;105:20.
    PubMed     Text format    
    
    

    
    J Biol Chem

79. SUBBARAMAIAH K, Hudis C, Chang SH, Hla T, et al
    Withdrawal: EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells: Evidence of a BRCA1 and p300 exchange.
    J Biol Chem. 2020;295:295.
    PubMed     Text format    
    
    

    
    J Natl Cancer Inst

80. ARTHUR RS, Wang T, Xue X, Kamensky V, et al
    Genetic factors, adherence to healthy lifestyle behavior, and risk of invasive breast cancer among women in the UK Biobank.
    J Natl Cancer Inst. 2020 Jan 3. pii: 5695712. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Surg Oncol

81. POMPONIO MK, Burkbauer L, Goldbach M, Nazarian SM, et al
    Refining the indications for neoadjuvant chemotherapy for patients with HER2+ breast cancer: A single institution experience.
    J Surg Oncol. 2020 Jan 9. doi: 10.1002/jso.25814.
    PubMed     Text format     Abstract available
    
    

    
    Lancet

82. THE LANCET
    Biosimilars: a new era in access to breast cancer treatment.
    Lancet. 2020;395:2.
    PubMed     Text format    
    
    

    
    Lancet Oncol

83. NUZZOLESE I, Montemurro F
    Attrition in metastatic breast cancer: a metric to be reported in randomised clinical trials?
    Lancet Oncol. 2020;21:21-24.
    PubMed     Text format    
    
    

    
    N Engl J Med

84. HAYES DF
    Progress in the Treatment of Breast Cancer. Reply.
    N Engl J Med. 2020;382:e4.
    PubMed     Text format    
    
    
85. KONNER M
    Progress in the Treatment of Breast Cancer.
    N Engl J Med. 2020;382:e4.
    PubMed     Text format    
    
    

    
    Nature

86. MCKINNEY SM, Sieniek M, Godbole V, Godwin J, et al
    International evaluation of an AI system for breast cancer screening.
    Nature. 2020;577:89-94.
    PubMed     Text format     Abstract available
    
    
87. PISANO ED
    AI shows promise for breast cancer screening.
    Nature. 2020;577:35-36.
    PubMed     Text format    
    
    

    
    Oncol Rep

88. JUNG KH, Lee JH, Park JW, Moon SH, et al
    Troglitazone exerts metabolic and antitumor effects on T47D breast cancer cells by suppressing mitochondrial pyruvate availability.
    Oncol Rep. 2019 Dec 16. doi: 10.3892/or.2019.7436.
    PubMed     Text format     Abstract available
    
    
89. ZHAO C, Zheng S, Yan Z, Deng Z, et al
    CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2.
    Oncol Rep. 2019 Dec 11. doi: 10.3892/or.2019.7426.
    PubMed     Text format     Abstract available
    
    
90. SHEVCHENKO JA, Khristin AA, Kurilin VV, Kuznetsova MS, et al
    Autologous dendritic cells and activated cytotoxic Tcells as combination therapy for breast cancer.
    Oncol Rep. 2019 Dec 16. doi: 10.3892/or.2019.7435.
    PubMed     Text format     Abstract available
    
    

    
    Oncology

91. SULEMAN K, Almalik O, Haque E, Mushtaq A, et al
    Does the Timing of Surgery after Neoadjuvant Therapy in Breast Cancer Patients Affect the Outcome?
    Oncology. 2020 Jan 9:1-6. doi: 10.1159/000504964.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Genet

92. PIGGIN CL, Roden DL, Law AMK, Molloy MP, et al
    ELF5 modulates the estrogen receptor cistrome in breast cancer.
    PLoS Genet. 2020;16:e1008531.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Med

93. GRAY E, Marti J, Wyatt JC, Brewster DH, et al
    Chemotherapy effectiveness in trial-underrepresented groups with early breast cancer: A retrospective cohort study.
    PLoS Med. 2019;16:e1003006.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

94. JAMSHIDII N, Chang J, Mock K, Nguyen B, et al
    Evaluation of the predictive ability of ultrasound-based assessment of breast cancer using BI-RADS natural language reporting against commercial transcriptome-based tests.
    PLoS One. 2020;15:e0226634.
    PubMed     Text format     Abstract available
    
    
95. PERRIER A, Boelle PY, Chretien Y, Gligorov J, et al
    An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies.
    PLoS One. 2020;15:e0227356.
    PubMed     Text format     Abstract available
    
    
96. WANG Q, Liu X, Ren S
    Tofu intake is inversely associated with risk of breast cancer: A meta-analysis of observational studies.
    PLoS One. 2020;15:e0226745.
    PubMed     Text format     Abstract available
    
    
97. GRESNER P, Jablonska E, Gromadzinska J
    Rad51 paralogs and the risk of unselected breast cancer: A case-control study.
    PLoS One. 2020;15:e0226976.
    PubMed     Text format     Abstract available
    
    

    
    Radiology

98. COOLEN AMP, Korte B, Tjan-Heijnen VCG, Bodewes HW, et al
    Additional Breast Cancer Detection at Digital Screening Mammography through Quality Assurance Sessions between Technologists and Radiologists.
    Radiology. 2020 Jan 7:191388. doi: 10.1148/radiol.2019191388.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: